✦ LIBER ✦

The influence of insulin pump treatment on metabolic syndrome parameters in type 2 diabetes mellitus

✍ Scribed by Zdenek Jankovec; Daniela Cechurova; Michal Krcma; Silvie Lacigova; Michal Zourek; Zdenek Rusavy

Publisher: Springer Vienna
Year: 2009
Tongue: English
Weight: 517 KB
Volume: 121
Category: Article
ISSN: 0043-5325
DOI: 10.1007/s00508-009-1203-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Laparoscopic treatment of metabolic synd

Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus

✍ A. L. DePaula; A. L. V. Macedo; N. Rassi; S. Vencio; C. A. Machado; B. R. Mota; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 312 KB

Laparoscopic treatment of metabolic synd

Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus

✍ A. L. DePaula; A. L. V. Macedo; N. Rassi; S. Vencio; C. A. Machado; B. R. Mota; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 312 KB

Long-term effect of intensified insulin

Long-term effect of intensified insulin treatment on lipid parameters in diabetes mellitus type I

✍ Dzien, A. ;Lechleitner, M. ;Hopferwieser, T. ;Drexel, H. ;Patsch, J. R. ;Braunst 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 283 KB

Influence of short term verapamil treatm

Influence of short term verapamil treatment on glucose metabolism in patients with non-insulin dependent diabetes mellitus

✍ M. Busch Sørensen; H. Sjøstrand; H. Sengeløv; M. Tiefenthal Thrane; J. Juul Hols 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 360 KB

Different effects of insulin and oral an

Different effects of insulin and oral antidiabetic agents on glucose and energy metabolism in Type 2 (non-insulin-dependent) diabetes mellitus

✍ L. Groop; E. Widén; A. Franssila-Kallunki; A. Ekstrand; C. Saloranta; C. Schalin 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 827 KB

Pravastatin compared to bezafibrate in t

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva